# A Study on Antiviral Treatment of Chronic Hepatitis B in Children

> **NCT05792761** · NA · UNKNOWN · sponsor: **Fang Wang** · enrollment: 1900 (estimated)

## Conditions studied

- Chronic HBV Infection

## Interventions

- **DRUG:** Peginterferon alfa-2b combined and ETV

## Key facts

- **NCT ID:** NCT05792761
- **Lead sponsor:** Fang Wang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-06
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 1900 (ESTIMATED)
- **Last updated:** 2023-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05792761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05792761, "A Study on Antiviral Treatment of Chronic Hepatitis B in Children". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05792761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*